en
Scientific article
Open access
English

Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials

Published inArchives of Medical Science, vol. 12, no. 6, p. 1181-1187
Publication date2016
Abstract

Alteplase and tenecteplase are two widely used thrombolytic agents and are both approved for the treatment of acute myocardial infarction. These two molecules have increased fibrin specificity compared with older thrombolytics but distinct pharmacokinetic properties and may differ in terms of risks and benefits. We decided to review the available evidence comparing the safety and efficacy of these two molecules in acute coronary syndrome (ACS) or pulmonary embolism (PE).

Citation (ISO format)
GUILLERMIN, Alexandre et al. Safety and efficacy of tenecteplase versus alteplase in acute coronary syndrome: a systematic review and meta-analysis of randomized trials. In: Archives of Medical Science, 2016, vol. 12, n° 6, p. 1181–1187. doi: 10.5114/aoms.2016.58929
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1734-1922
589views
252downloads

Technical informations

Creation04/11/2017 09:19:00
First validation04/11/2017 09:19:00
Update time15/03/2023 02:17:10
Status update15/03/2023 02:17:09
Last indexation17/01/2024 01:14:44
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack